Table 1.

Candidate Genes Mapped to Regions of Amplification Identified by CGH

Chromosomal Region Candidate Genes Normal FunctionAmplification in Tumorigenesis
1q21-23  IL6R  Signal transduction (receptor)13  
 MCL1  Apoptosis (BCL2 family member)14  
 SKI  Transcription factor15  
2p12-16  REL  Transcription factor16  DLBL6  
8q24  MYC Transcription factor17  Breast carcinoma,18 Ovarian carcinoma,19FCL20 
9q34  ABL  Signal transduction (kinase)21  
 TAN1  Signal transduction (receptor)22  
12q12-14  CDK2  Cell cycle kinase23  Colorectal carcinoma24  
 GLI Transcription factor25  Gliomas,26Sarcomas27  
 SAS  Transmembrane protein28  Gliomas,29 Sarcomas28  
 CDK4  Cell cycle kinase23  Gliomas,29 Sarcomas30  
 MDM2  p53 inactivation31  Gliomas,29Sarcomas30  
13q32  —  —  —  
16p12  IL4R  Signal transduction (receptor)32  
18q21-22  BCL2 Apoptosis14  NHL,33 DLBL7  
22q12  SIS/YES2  Growth factor34  Atypical NHL35 
Chromosomal Region Candidate Genes Normal FunctionAmplification in Tumorigenesis
1q21-23  IL6R  Signal transduction (receptor)13  
 MCL1  Apoptosis (BCL2 family member)14  
 SKI  Transcription factor15  
2p12-16  REL  Transcription factor16  DLBL6  
8q24  MYC Transcription factor17  Breast carcinoma,18 Ovarian carcinoma,19FCL20 
9q34  ABL  Signal transduction (kinase)21  
 TAN1  Signal transduction (receptor)22  
12q12-14  CDK2  Cell cycle kinase23  Colorectal carcinoma24  
 GLI Transcription factor25  Gliomas,26Sarcomas27  
 SAS  Transmembrane protein28  Gliomas,29 Sarcomas28  
 CDK4  Cell cycle kinase23  Gliomas,29 Sarcomas30  
 MDM2  p53 inactivation31  Gliomas,29Sarcomas30  
13q32  —  —  —  
16p12  IL4R  Signal transduction (receptor)32  
18q21-22  BCL2 Apoptosis14  NHL,33 DLBL7  
22q12  SIS/YES2  Growth factor34  Atypical NHL35 

or Create an Account

Close Modal
Close Modal